3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Leukopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arseneau, JC; Blessing, JA; Homesley, HD; Thigpen, JT | 1 |
| Adcock, LL; Blessing, J; Homesley, HD; Thigpen, JT | 1 |
| Blessing, JA; Curry, SL; Hacker, N; Homesley, HD; Thigpen, JT | 1 |
3 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukopenia
| Article | Year |
|---|---|
Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Ovarian Neoplasms; Piperazines; Thrombocytopenia; Uremia | 1984 |
Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Thrombocytopenia; Uterine Cervical Neoplasms | 1983 |
Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Piperazines; Sarcoma; Thrombocytopenia; Uterine Neoplasms | 1985 |